For: | Papadopoulos VP, Mimidis K. Corrected QT interval in cirrhosis: A systematic review and meta-analysis. World J Hepatol 2023; 15(9): 1060-1083 [PMID: 37900213 DOI: 10.4254/wjh.v15.i9.1060] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v15/i9/1060.htm |
Number | Citing Articles |
1 |
Yishan Wang, Qin Hu, Haixia Zhao, Lulu Zeng, Zhongwei Zhao, Xia Li, Qiaoyou Weng, Yang Yang, Minjiang Chen, Jiansong Ji, Rongfang Qiu. PHF20L1: An Epigenetic Regulator in Cancer and Beyond. Biomolecules 2025; 15(7): 1048 doi: 10.3390/biom15071048
|
2 |
Huanqin Han, Junlian Chen, Zhirong Deng, Tingting Li, Xiaoying Qi, Wei Deng, Zunge Wu, Chuli Xiao, Weiqiang Zheng, Yujun Du. Propranolol can correct prolonged QT intervals in patients with cirrhosis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1370261
|
3 |
Andrew Ndakotsu, Tagbo Charles Nduka, Simran Agrawal, Edinen Asuka. Cirrhotic cardiomyopathy: comprehensive insights into pathophysiology, diagnosis, and management. Heart Failure Reviews 2025; 30(4): 739 doi: 10.1007/s10741-025-10500-7
|
4 |
V. V. Genkel, V. N. Pospelov, A. S. Kuznetsova, N. V. Smagina, E. O. Vedernikova, S. M. Ashmarina, I. I. Shaposhnik. Duration and dispersion of QT interval in patients with liver cirrhosis: diagnostic and prognostic value. Сибирский научный медицинский журнал 2025; 45(1): 139 doi: 10.18699/SSMJ20250115
|